These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Legal aspects of gene technology in medical research. Hasskarl H Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):501-3. PubMed ID: 7885076 [No Abstract] [Full Text] [Related]
43. International Workshop on Legal Aspects of the Human Genome Project (Bilbao, 24-26 May 1993) adopts Bilbao Declaration. Int Dig Health Legis; 1994; 45(2):234-7. PubMed ID: 11659960 [No Abstract] [Full Text] [Related]
46. Gene technology and democracy. Olson H Science; 1998 Jan; 279(5348):157. PubMed ID: 9446213 [No Abstract] [Full Text] [Related]
47. The dilemmas of German bioethics. Brown E New Atlantis; 2004; 5():37-53. PubMed ID: 15586957 [No Abstract] [Full Text] [Related]
48. Regulation and exploitation of genetically modified crops. Kleter GA; van der Krieken WM; Kok EJ; Bosch D; Jordi W; Gilissen LJ Nat Biotechnol; 2001 Dec; 19(12):1105-10. PubMed ID: 11731773 [No Abstract] [Full Text] [Related]
49. GM crops and equivocal environmental benefits. Johnson B; Hope A Nat Biotechnol; 2000 Mar; 18(3):242. PubMed ID: 10700091 [No Abstract] [Full Text] [Related]
50. Biologists mobilize against anti-genetics referendum. Koenig R Science; 1997 Jan; 275(5300):607-8. PubMed ID: 9019813 [No Abstract] [Full Text] [Related]
51. Preliminary draft of a Universal Declaration on the Human Genome and Human Rights. Unesco. International Bioethics Committee Politics Life Sci; 1996 Sep; 15(2):332-4. PubMed ID: 11654812 [No Abstract] [Full Text] [Related]
52. [Openness, social security number and confidence. Ethical rules as a competitive agent for biobanks and genome firms]. Fällman H Lakartidningen; 1999 Nov; 96(45):4950-2. PubMed ID: 10596539 [No Abstract] [Full Text] [Related]
53. [Medical research without genetic technology?]. Weibel ER Schweiz Med Wochenschr; 1998 Apr; 128(15):561-2. PubMed ID: 9606796 [No Abstract] [Full Text] [Related]
57. Putting Cartagena into practice. Watanabe KN; Taeb M; Okusu H Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448 [No Abstract] [Full Text] [Related]
58. EU plans to label and trace GMOs. Dorey E Nat Biotechnol; 2001 Sep; 19(9):795. PubMed ID: 11533623 [No Abstract] [Full Text] [Related]
59. The biotechnology revolution and its regulatory evolution. Hoffman DE Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466 [No Abstract] [Full Text] [Related]
60. Designer babies: are test tubes and microbes replacing romance? relevant legal issues and DNA. Miller K; Kohm LM Am J Forensic Med Pathol; 1996 Dec; 17(4):305-7. PubMed ID: 8947354 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]